关闭
 
读者在线:用户名 密码
首页 期刊简介 投稿须知 期刊目录 专家风采 编委会 特邀顾问 联系我们 移动出版
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5



刊物信息

期刊名称:药物分析杂志
主管单位:中国科学技术协会
主办单位:中国药学会
承办:中国食品药品检定研究院
主编:金少鸿
地址:北京天坛西里2号
邮政编码:100050
电话:010-67012819,67058427
电子邮箱:ywfx@nifdc.org.cn
国际标准刊号:ISSN 0254-1793
国内统一刊号:CN 11-2224/R
邮发代号:2-237
 

访问统计
您是第  1 0 5 2 2 7 8 9 位浏览者
您当前的位置:首页 >> 正文

HPLC-MS/MS法分析吉非替尼中痕量基因毒性杂质

Trace determination of genotoxic impurity in gefitinib by HPLC-MS/MS

作者(英文):
分类号:R917
出版年·卷·期(页码):2017,37 (7):1309-1313
DOI: 10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------

目的:建立液相色谱-串联质谱法测定吉非替尼中基因毒性杂质的含量。方法:采用Accucore C18色谱柱(2.1 mm&#215;100 mm,2.6 μm),以0.1%甲酸水溶液-0.1%甲酸乙腈溶液(70:30)为流动相,流速0.3 mL&#183;min-1,柱温30 ℃;采用ESI离子源正离子模式,多反应离子监测(MRM)模式下选择离子对m/z130.1→83.1(3,4-二氟苯胺)和m/z146.0→111.0(4-氯-3-氟苯胺)进行测定。结果:基因毒性杂质3,4-二氟苯胺和4-氯-3-氟苯胺的线性浓度范围为1~24 ng&#183;mL-1,且线性关系良好(r=0.999 4、r=0.999 2);检测限为0.2 mg&#183;kg-1,定量限为0.5 mg&#183;kg-1;3,4-二氟苯胺和4-氯-3-氟苯胺的精密度试验的RSD(n=6)分别为2.3%和2.0%;杂质3,4-二氟苯胺低、中、高浓度的加标回收率(n=3)分别为99.4% 、97.0% 、105.5% ,RSD=8.2% 、5.1% 、1.7%;杂质4-氯-3-氟苯胺低、中、高浓度的加标回收率(n=3)分别为102.0% 、98.6% 、106.0% ,RSD分别为3.9% 、7.9% 、2.4%。经检测,3批吉非替尼供试品中3,4-二氟苯胺均未检出,批号2吉非替尼样品中4-氯-3-氟苯胺有少量检出,但低于样品的定量限(<0.5mg·kg-1)。结论:本方法操作简便,结果可靠,经方法学验证,可用于吉非替尼药物中基因毒性杂质3,4-二氟苯胺和4-氯-3-氟苯胺含量的同时测定。

-----英文摘要:---------------------------------------------------------------------------------------

Objective: To establish an HPLC-MS/MS analytical method for the determination of genotoxic impurity in Gefitinib. Methods: The analytical column was ThermoAccucore C18(2.1 mm&#215;100 mm, 2.6 μm), the mobile phase was 0.1% formic acidsolution-0.1% formic acid acetonitrile(70: 30), and the flow rate was 0.3mL&#183;min-1. The column temperature was set at 30 ℃. The detection was achieved in ESI positive ion mode with m/z 130.1→83.1 for the determination of 3, 4-difluoroaniline and m/z 146.0→111.0 for 4-chloro-3-fluoroaniline. Results: The calibration curve of 3, 4-difluoroaniline and 4-chloro-3-fluoroaniline were in a good linearity over the range of 1-24 ng&#183;mL-1(r=0.999 4 and 0.999 2, respectively). The limit of detection was 0.2 mg&#183;kg-1, and the limit of quantification was 0.5 mg&#183;kg-1. Repetition of genotoxic impurity was fine, with RSD(n=6)of 2.3% and 2.0%, respectively. The recoveries(n=3)of low, middle and high adding concentrations of 3, 4-difluoroaniline were 99.4%, 97.0%, 105.5%, respectively, and inter-day RSD were 8.2%, 5.1%, 1.7%, respectively. The recoveries(n=3)of low, middle and high adding concentrations of 4-chloro-3-fluoroaniline were 102.0%, 98.6%, 106.0%, respectively, and inter-day RSD were 3.9%, 7.9%, 2.4%, respectively. 3, 4-Difluoroaniline was not detected in 3 batches of samples and 4-chloro-3-fluoroaniline in batch number 2 was detected in trace amount, lower than the limit of quantification(<0.5 mg&#183;kg-1). Conclusion: The established method is simple, rapid and reliable, which is applicable for both quantification of 3, 4-difluoroaniline and 4-chloro-3-fluoroaniline in Gefitinib.

-----参考文献:---------------------------------------------------------------------------------------

欢迎阅读《药物分析杂志》!您是该文第 326位读者!

药物分析杂志 © 2009
地址:北京天坛西里2号 邮政编码:100050; 电子邮件:ywfx@nicpbp.org.cn